138 related articles for article (PubMed ID: 9298303)
21. Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.
Ciarmiello A; Del Vecchio S; Silvestro P; Potena MI; Carriero MV; Thomas R; Botti G; D'Aiuto G; Salvatore M
J Clin Oncol; 1998 May; 16(5):1677-83. PubMed ID: 9586878
[TBL] [Abstract][Full Text] [Related]
22. Success of neoadjuvant chemotherapy in conversion of mastectomy to breast conservation surgery.
Kaufmann P; Dauphine CE; Vargas MP; Burla ML; Isaac NM; Gonzalez KD; Rosing D; Vargas HI
Am Surg; 2006 Oct; 72(10):935-8. PubMed ID: 17058739
[TBL] [Abstract][Full Text] [Related]
23. Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
Rodenhuis S; Richel DJ; van der Wall E; Schornagel JH; Baars JW; Koning CC; Peterse JL; Borger JH; Nooijen WJ; Bakx R; Dalesio O; Rutgers E
Lancet; 1998 Aug; 352(9127):515-21. PubMed ID: 9716055
[TBL] [Abstract][Full Text] [Related]
24. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of (99m)Tc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer.
Alonso O; Delgado L; Núñez M; Vargas C; Lopera J; Andruskevicius P; Sabini G; Gaudiano J; Musé IM; Roca R
Nucl Med Commun; 2002 Aug; 23(8):765-71. PubMed ID: 12124482
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.
Sciuto R; Pasqualoni R; Bergomi S; Petrilli G; Vici P; Belli F; Botti C; Mottolese M; Maini CL
J Nucl Med; 2002 Jun; 43(6):745-51. PubMed ID: 12050317
[TBL] [Abstract][Full Text] [Related]
27. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer.
Denis F; Desbiez-Bourcier AV; Chapiron C; Arbion F; Body G; Brunereau L
Eur J Surg Oncol; 2004 Dec; 30(10):1069-76. PubMed ID: 15522553
[TBL] [Abstract][Full Text] [Related]
28. Monitoring the response of large (>3 cm) and locally advanced (T3-4, N0-2) breast cancer to neoadjuvant chemotherapy using (99m)Tc-Sestamibi uptake.
Marshall C; Eremin J; El-Sheemy M; Eremin O; Griffiths PA
Nucl Med Commun; 2005 Jan; 26(1):9-15. PubMed ID: 15604942
[TBL] [Abstract][Full Text] [Related]
29. The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer.
Nolan L; Darby A; Boleti K; Simmonds P
Breast; 2011 Apr; 20(2):151-4. PubMed ID: 20970333
[TBL] [Abstract][Full Text] [Related]
30. Recall phenomenon following epirubicin.
Wilson J; Carder P; Gooi J; Nishikawa H
Clin Oncol (R Coll Radiol); 1999; 11(6):424-5. PubMed ID: 10663338
[TBL] [Abstract][Full Text] [Related]
31. First-line chemotherapy with liposomal doxorubicin plus cyclofosfamide in metastatic breast cancer: a case report of early and prolonged response.
Riccardi F; Mocerino C; Barbato C; Ambrosio F; Festino L; Vitale MG; Carrillo G; Trunfio M; Minelli S; Carteni G
Int J Immunopathol Pharmacol; 2013; 26(3):773-8. PubMed ID: 24067476
[TBL] [Abstract][Full Text] [Related]
32. [Response evaluation with mammography and ultrasound].
Junkermann H; Schmid H; Sinn HP; Wallwiener D
Zentralbl Gynakol; 1996; 118(10):572-3. PubMed ID: 8999712
[No Abstract] [Full Text] [Related]
33. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
[TBL] [Abstract][Full Text] [Related]
34. Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients.
Jensen SB; Mouridsen HT; Bergmann OJ; Reibel J; Brünner N; Nauntofte B
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Aug; 106(2):217-26. PubMed ID: 18554960
[TBL] [Abstract][Full Text] [Related]
35. The effect of chemotherapy on the uptake of technetium-99m sestamibi in breast cancer.
Cwikla JB; Buscombe JR; Barlow RV; Kelleher SM; Parbhoo SP; Crow J; Deery A; Jones AL; Hilson AJ
Eur J Nucl Med; 1997 Sep; 24(9):1175-8. PubMed ID: 9283114
[TBL] [Abstract][Full Text] [Related]
36. [Primary systemic therapy in breast cancer patients (2007-2010)].
Zapf I; Tizedes G; Pavlovics G; Kovács G; Kálmán E; Szalai G; Kövér E; Farkas R; Horváth OP
Magy Seb; 2011 Oct; 64(5):223-8. PubMed ID: 21997525
[TBL] [Abstract][Full Text] [Related]
37. Detection of axillary lymph node metastasis of breast carcinoma with technetium-99m sestamibi scintimammography.
Tolmos J; Khalkhali I; Vargas H; Stuntz M; Cutrone J; Mishkin F; Diggles L; Venegas R; Klein S
Am Surg; 1997 Oct; 63(10):850-3. PubMed ID: 9322655
[TBL] [Abstract][Full Text] [Related]
38. Parotid gland metastasis of a breast cancer.
Perez-Fidalgo JA; Chirivella I; Laforga J; Colio JM; Blanes MD; Baydal R; Roselló S; De-la-Morena E; Lluch A
Clin Transl Oncol; 2007 Apr; 9(4):264-5. PubMed ID: 17462982
[TBL] [Abstract][Full Text] [Related]
39. Ethmoid sinus leiomyosarcoma after cyclophosphamide treatment.
Reich DS; Palmer CA; Peters GE
Otolaryngol Head Neck Surg; 1995 Oct; 113(4):495-8. PubMed ID: 7567030
[No Abstract] [Full Text] [Related]
40. Utility of technetium-99m methoxyisobutyl isonitrile uptake analysis for prediction of the response to chemotherapy in advanced and relapsed breast cancer.
Kim R; Osaki A; Hirai T; Toge T
Breast Cancer; 2002; 9(3):240-7. PubMed ID: 12185336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
